FORMULATION AND OPTIMIZATION OF LEVAMISOLE CHEWABLE TABLETS
DOI:
https://doi.org/10.22159/ijap.2019v11i6.34413Keywords:
Levamisole, Chewable tablet, Superdisintegrant, Sodium starch glycolate, DRC, DRC Indion 204, DRC Indion 234Abstract
Objective: The aim of the present study was to prepare and optimize levamisole chewable tablets by using various super disintegrants, namely; sodium starch glycolate, DRC Indion 204, and DRC Indion 234.
Methods: Drug excipient compatibility study was carried out by FTIR spectroscopy to verify the compatibility of levamisole with the excipients. Nine batches of levamisole chewable tablets were prepared according to 32 factorial designs using a direct compression method by optimizing the super disintegrant concentration. The powder blend was exposed to pre-compression studies of the powder blend followed by post-compression studies of the formulated tablets.
Results: FTIR study revealed that the excipients used in the formulations were compatible with the drug. The pre-compression and post-compression parameters were found within the IP limits. Form the dissolution studies, it was evident that the formulation prepared with DRC Indion 234 (50 mg) showed maximum percentage drug release in 45 min (97.13%) hence it is considered as optimized formulation. When compared to all other formulation, the batches with DRC Indion 234 (F7-F9) showed a better release of the drug (90 % drug release within 45 min).
Conclusion: Nine batches of levamisole chewable tablets were successfully formulated by optimizing the concentration of super disintegrants such as sodium starch glycolate, DRC Indion 204, and DRC Indion 234. It was concluded from the dissolution studies that the DRC Indion 234 is the best super disintegrant irrespective of their concentration for the formulation of levamisole chewable tablets when compared to sodium starch Glycolate and DRC Indion 204.
Downloads
References
Herbert AL, Libermann, Leon L. Pharmaceutical dosage from tablets. New York: Marcel Dekker Inc; 1980. p. 298-337.
Reeta RT, Sonia N. Orally disintegrating preparations: Recent advancement in formulation and technology. J Drug Delivery Ther 2012;2:87-96.
Raghavendra RNG, Sanjeeva NB, Santhosh KB, Kistayya C. Design and development of taste masked oral disintegrating tablet of ondansetron hydrochloride. Res J Pharm 2017;7:58-64.
Renu, Jyoti D, Pawan J, Balvinder S. Chewable tablets: a comprehensive review. Pharm Innov J 2015;4:100-5.
Somchai S, Apichart A, Attawadee SY, Teerapol S, Narumon C, Tan. Formulation development of albendazole-loaded self-microemulsifying chewable tablets to enhance dissolution and bioavailability S. Pharm 2019;11:1-20.
Anusha V, Palanichamy S, Sugumar M, Rajesh M, Parasakthi N, Godwin RD, et al. Formulation and characterization of albendazole chewable tablets. Der Pharm Sin 2012;3:211-6.
Suzuki H, Onishi H, Takahashi Y, Iwata M, Machi-da Y. Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm 2003;251:123-32.
Howard CA, Nicholas GP, Loyd VA. Pharmaceutical dosage form and drug delivery system. 6th ed. New Delhi: B. I. Waverty Pvt Ltd; 1995. p. 230, 655-8.
Alfred M, Pilar, Bustamante, Chun AHS. A textbook of physical pharmacy. 4th ed. New Delhi: B. I. Waverty Pvt Ltd; 1994.
Laxman D, Bhupendra KP, Junu KS. Formulation and in vitro evaluation of chewable tablets of montelukast sodium. Int J Drug Delivery Tech 2014;5:98-103.
Padmasri B, Kalyani R, Deepthi KL, Anil KV, Prasanth D. Formulation and evaluation of darunavir chewable tablets. Int J Pharm Anal Res 2015;5:400-8.
Fatima SD, Komal S, Sholapur HN, Nanjundaswamy NG, Sajjanar VM. Design, optimization and evaluation of chewable tablets of clarithromycin using ion exchange resins. Indian J Pharm Sci 2016;78:818-26.
Vandamme TF, Demoustier M, Rollmann B. Quantitation of levamisole in plasma using high performance liquid chromatography. Eur J Drug Metab Pharmacokinet 1995;20:145-9.
Koyma K, Oshi T, Ishii A, Deguchi T. Levamisole: metabolic fate of levamisole in rats, dogs and monkey. Oyo Yakuri 1983;26:869-76.
Jayalakshmi K, Dungrani J, Johnson M. Preparation and in vitro evaluation of levamisole hydrochloride as a candy based anthelmintic medicated lollipops for pediatrics. Int J Pharm Sci Res 2012;3:523-34.
Praveen N, Ramesh Y, Gnanaprakash K, Gobinath M, Mahesh N, Monica A. Formulation and evaluation of levamisole oral dispersible tablets. Int J Res Pharm Sci 2015;6:256-61.
Adams JG. Pharmacokinetics of levamisole. J Rheumatol Suppl 1978;4:137-42.
Barker SA. The formation of aminorex in racehorses following levamisole administration. A quantitative and chiral analysis following synthetic aminorex or levamisole administration vs. aminorex-positive samples from the field: a preliminary report. J Vet Pharmacol Ther 2009;32:160-6.
Sabina A, Pulak D. Formulation and evaluation of chewable multivitamin tablet. Int J Curr Pharm Res 2017;9:61-4.
Syed NU, Anup KR, Martand K, Vinod KSM. Formulation and evaluation of sustained release matrix tablets of lornoxicam. Int J Drug Dev Res 2011;3:31-44.
Leon L, Herbert AL, Joseph LK. The theory and practice of industrial pharmacy. Bombay: Varghese Publishing House; 1987.
Debjit B, Chiranjib B, Krishnakanth, Pankaj, Margret CR. Fast dissolving tablet: an overview. J Chem Pharma Res 2009;1:163-77.
Jashabir C, Suvakanta D, Biswajit D. Formulation and evaluation of controlled release mucoadhessive matrix tablets of levamisole: assement of purified fruit pulp polysaccharide isolated from aegle marmelos as mucoadhesive excipient. Asian J Pharm Clin Res 2015;8:262-9.
Harshada AK, Asish D, Subhakanta D. Formulation and evaluation of lidocaine hydrochloride chewable tablet. Asian J Pharm Clin Res 2018;11:190-4.
Stephanie TG, Emmanuel NN. Quality control evaluation of brands of mebendazole 100 mg tablets on the illegitimate pharmacy outlets. Int J Pharm Pharm Sci 2018;6:355-7.
Farzana H, Sharja N, Hasib AH, Shamima N. Comparative bioequivalence study of different brands of valsartan tablets marketed in Bangladesh by dissolution modeling and quality control tests. W J Pharm Pharm Sci 2017;6:112-21.
Rakshita AS, Shashank NN, Shwetha S, Kamath K. Study of post compression parameters of various marketed paracetamol tablets in India. Pharma Tutor 2019;7:35-42.
Ronald P, Shashank NN, Shwetha SKK, Shabaraya AR. Formulation and evaluation of fast dissolving tablets of flunarizine hydrochloride by sublimation method using sodium starch glycolate as superdisintegrant. Int J PharmTech Res 2014;6:1085-95.
Sunidhi M, Shivali S, Sachin G, Bhimi K, Abhishek S. Formulation and evaluation of mouth dissolving tablets of ondansetron hydrochloride using plantago ovata (isapghula) mucilage as a natural super disintegrating agent. Int J Pharm Sci Drug Res 2017;9:240-6.
Abdullah AR, Tariqul I, Sazaul MS, Faruk H. Comparative study on quality analysis on marketed diclofenac sodium tablets of different brands available in Bangladesh. Res J Life Sci Bioinform Pharm Chem Sci 2018;4:362-73.
Kadria AE, Maha AH, Samar AA. Formulation and optimization of orodispersible tablets of flutamide. Saudi Pharm J 2014;22:51-61.
Shwetha SKK, Shashank NN, Srinivas H, Shabaraya AR. Design and evaluation of fast dissolving tablet of caffeine by using natural super disintegrant. Inventi Rapid: Pharm Tech 2013;13:1-4.
Shashank NN, Shwetha SKK, Arpit SP, Srinivas H, Shabaraya AR. Formulation and evaluation of fast dissolving tablet of caffeine by sublimation method. Inventi Rapid: Pharm Tech 2013;13:1-4.
Mohammad S, Mohammad S, Bijja S, Ashraf B. Evaluation of tablets by friability apparatus. Int J Res Pharm Chem 2014;4:837-40.
Raghavendra RNG, Sanjeeva NB, Santhosh KB, Kistayya C. Design and development of taste-masked oral disintegrating tablet of ondansetron hydrochloride. Res J Pharm 2017;7:58-64.
Chauhan R, Dewangan DK, Dwivedi J, Jha AK. Effects of granule particle size and lubricant concentration on tablet hardness containing large concentration of polymers. Braz J Pharm Sci 2017;53:1-8.
Parind MD, Celine VL, Paul WSH. Review of disintegrants and the disintegration phenomena. J Pharm Sci 2016;105:2545-55.
Published
How to Cite
Issue
Section
